Biosimilars portfolio acquisition: Smart proven strategy
Biosimilars portfolio acquisition is reshaping the market with Adalvo's latest move.
Biosimilars portfolio acquisition is reshaping the market with Adalvo's latest move.
Cancer drug price cut brings new rates for 543 brands effective November 9. Discover the details now.
Weight loss drug price cut is making headlines. Discover if this change is worth it for consumers looking for affordable options.
Cevimeline HCl approval marks a significant milestone for Cosette. Discover its implications for the pharma industry.
USFDA approval otic suspension marks a significant milestone for Alembic Pharmaceuticals, enhancing treatment options.
FDA approval schizophrenia treatment brings new hope for patients struggling with mental health issues.
Cancer drug prices may decrease as the government plans a 30% trade margin cap, offering potential savings for patients.
Aurobindo Pharma USFDA approval has sparked a rally, reaching a new 52-week high. Discover what this means for investors.